WCN26-5440 A CASE OF LIVER INJURY IN AN ELDERLY PATIENT WITH DIABETES AND ANCA-ASSOCIATED VASCULITIS DURING AVACOPAN USE

Read full text Summarise with VIRAT
Authors: Yoko Nishijima, Tadashi Sofue
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Avacopan, an oral C5a receptor antagonist, has been demonstrated to be effective in inducing and maintaining remission in microscopic polyangiitis(MPA), with the additional benefit of reducing glucocorticoid exposure and associated toxicity. Among its side effects, liver injury is the most common, occurring in 16.7–40.9% of cases in Japanese cohorts.

Fields of Study & Subjects

Vasculitis and related conditions Complement system in diseases Pharmacovigilance and Adverse Drug Reactions

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106242–106242
Publication date
25 March 2026
Language
EN